Business
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2025.
About this update from Kewaunee Scientific Corporation
[{"type":"text","content":"STATESVILLE, N.C., June 25, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fourth quarter and its fiscal year ended April 30, 2025.","length":184,"tagName":"p"},{"type":"image","alt":"Kewaunee Scientific Corporation (PRNewsFoto/Kewaunee Scientific Corporation)","displaySize":"","headline":null,"caption":"Kewaunee Scientific Corporation (PRNewsFoto/Kewaunee Scientific Corporation)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":310,"url":"https://media.zenfs.com/en/prnewswire.com/98854ca88d1eb37bddbcf2c5f6b6285d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Z8pgi6DARlTAWbCFDrXnnw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTU0NjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/98854ca88d1eb37bddbcf2c5f6b6285d","width":400,"height":310}},"href":"https://mma.prnewswire.com/media/338700/Kewaunee_Scientific_v1_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Fiscal Year 2025 Fourth Quarter Results","length":39,"tagName":"p","attribs":{}},{"type":"text","content":"Sales during the fourth quarter of fiscal year 2025 were $77,148,000, an increase of 36.1% compared to sales of $56,702,000 from the prior year's fourth quarter. Pre-tax earnings for the quarter were $7,149,000 compared to $1,347,000 for the prior year quarter. Net earnings for the quarter were $4,850,000 compared to net earnings of $11,026,000 for the prior year quarter. Diluted earnings per share were $1.63 compared to diluted earnings per share of $3.71 in the prior year quarter. EBITDA1 for the quarter was $9,671,000 compared to $2,265,000 for the prior year quarter.","length":581,"tagName":"p","attribs":{}},{"type":"text","content":"The Company's order backlog was $214.6 million on April 30, 2025, a slight decrease from $221.6 million on January 31, 2025, and an increase from $155.6 million on April 30, 2024.","length":183,"tagName":"p","attribs":{}},{"type":"text","content":"Prior Year Quarter Non-Recurring Transactions:","length":46,"tagName":"p","attribs":{}},{"type":"text","content":"During the fourth quarter of the previous fiscal year, two non-recurring transactions were recorded that impacted reported earnings and EBITDA which management believes should be considered when analyzing our financial results for the two most recent fiscal years...